DGAP-Adhoc: SREP capital requirements for Commerzbank to remain unchanged for 2022
2022. február 03., csütörtök, 20:09
DGAP-Ad-hoc: Commerzbank Aktiengesellschaft / Key word(s): Miscellaneous In the annual Supervisory Review and Evaluation Process (SREP) the European Central Bank (ECB) has confirmed that the bank-specific capital requirements for Commerzbank Group remain unchanged for 2022. The additional own funds requirement of Pillar 2 (P2R) of 2% can be fulfilled with CET 1 capital, additional tier 1 capital (AT 1) and Tier 2 capital. As of 30 September 2021, the pro forma Common Equity Tier 1 requirement for Commerzbank on group level stands at 9.40% of risk weighted assets (MDA threshold). This requirement consists of the CET1 minimum requirement of 4.5%, the pillar 2 requirement (P2R) of 1.125%, the capital conservation buffer of 2.5%, the O-SII capital buffer of 1.25% and the countercyclical capital buffer of currently 0.02%. With a CET 1 ratio of 13.5% as of 30 September 2021, the distance to the MDA threshold (Maximum Distributable Amount) is around 410 basis points above regulatory requirements. With effect from 1 March 2022, the SREP decision replaces the previous SREP decision of 10 December 2019. The ad hoc release is based on the revised MAR guidelines "postponement of the disclosure of inside information" of ESMA which provide for a corresponding publication of the P2R. Disclaimer Contact: Christoph Wortig Head of Investor Relations Commerzbank AG Investor Relations Tel.: +49 69 136 - 21331 e-mail:ir@commerzbank.com
|
Language: | English |
Company: | Commerzbank Aktiengesellschaft |
Kaiserstraße 16 | |
60311 Frankfurt am Main | |
Germany | |
Phone: | +49 (069) 136 20 |
Fax: | - |
E-mail: | pressestelle@commerzbank.com |
Internet: | www.commerzbank.de |
ISIN: | DE000CBK1001 |
WKN: | CBK100 |
Indices: | MDAX, CDAX, HDAX, PRIMEALL |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1276575 |
End of Announcement | DGAP News Service |
1276575 03-Feb-2022 CET/CEST
Közzétételek - archívum
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab
[2020.07.22. 15:00]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products
[2020.07.08. 17:15]